About Circadian Therapeutics
Circadian Therapeutics is a company based in Oxford (United Kingdom) founded in 2016 by Vasudevan, Maarten De Vos, Russell Foster, Jagannath, and Chris Blackwell.. Circadian Therapeutics has raised $12.04 million across 3 funding rounds from investors including Oxford Science Enterprises. The company has 3 employees as of December 31, 2022. Circadian Therapeutics offers products and services including Therapeutic Products. Circadian Therapeutics operates in a competitive market with competitors including Apnimed, Aculys, Avadel Pharmaceuticals, Mosanna Therapeutics and Somnus Therapeutics, among others.
- Headquarter Oxford, United Kingdom
- Employees 3 as on 31 Dec, 2022
- Founders Vasudevan, Maarten De Vos, Russell Foster, Jagannath, Chris Blackwell
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Circadian Therapeutics Limited
- Date of Incorporation 18 Jul, 2016
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
-
Net Profit
$-2.5 M (USD)47as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$12.04 M (USD)
in 3 rounds
-
Latest Funding Round
$3.76 M (USD), Seed
Feb 26, 2020
- Investors
-
Employee Count
3
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Circadian Therapeutics
Circadian Therapeutics offers a comprehensive portfolio of products and services, including Therapeutic Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats serious diseases by modulating circadian rhythms pharmacologically.
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Finance and Accounting
1 people
Chairman Team
1 people
Academic Team
1 people
Unlock access to complete
Funding Insights of Circadian Therapeutics
Circadian Therapeutics has successfully raised a total of $12.04M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3.76 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $3.8M
-
First Round
First Round
(09 Sep 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Seed - Circadian Therapeutics | Valuation |
investors |
|
| Dec, 2018 | Amount | Seed - Circadian Therapeutics | Valuation |
investors |
|
| Sep, 2016 | Amount | Seed - Circadian Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Circadian Therapeutics
Circadian Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Oxford Science Enterprises. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services for science ventures are provided in Oxford.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Circadian Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Circadian Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Circadian Therapeutics Comparisons
Competitors of Circadian Therapeutics
Circadian Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apnimed, Aculys, Avadel Pharmaceuticals, Mosanna Therapeutics and Somnus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for obstructive sleep apnea are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic medicines for neuropsychiatric and sleep disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proprietary drug delivery technologies and narcolepsy treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for sleep apnea are developed.
|
|
| domain | founded_year | HQ Location |
Controlled-release sleep maintenance therapeutics are developed by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Circadian Therapeutics
When was Circadian Therapeutics founded?
Circadian Therapeutics was founded in 2016.
Where is Circadian Therapeutics located?
Circadian Therapeutics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Circadian Therapeutics a funded company?
Circadian Therapeutics is a funded company, having raised a total of $12.04M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.67M, raised on Sep 09, 2016.
How many employees does Circadian Therapeutics have?
As of Dec 31, 2022, the latest employee count at Circadian Therapeutics is 3.
What does Circadian Therapeutics do?
Developer of therapeutics to treat circadian rhythm disruption. It offers multiple drug candidates CT-1500 adenosine receptor modulator, CT-2500 for Parkinsons, and Alzheimers, CT-2600 for neuropsychiatric disorders, and CT-3500 for metabolic disorders.
Who are the top competitors of Circadian Therapeutics?
Circadian Therapeutics's top competitors include Apnimed, Mosanna Therapeutics and Avadel Pharmaceuticals.
What products or services does Circadian Therapeutics offer?
Circadian Therapeutics offers Therapeutic Products.
Who are Circadian Therapeutics's investors?
Circadian Therapeutics has 1 investor. Key investors include Oxford Science Enterprises.
What is Circadian Therapeutics's valuation?
The valuation of Circadian Therapeutics is $7.38M as of Feb 2020.